DOCSLIB.ORG

In Vitro Evaluation of Antihelminthic Activity of Allium Sativum Against Adult Cotylophoron Cotylophorum (Paramphistomidae)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
In Vitro Evaluation of Antihelminthic Activity of Allium Sativum Against Adult Cotylophoron Cotylophorum (Paramphistomidae) ISSN: 0258-3216 Vol. 5, No. 2, 2012 RESEARCH ARTICLE PUJ In Vitro Evaluation of Antihelminthic Activity of Allium sativum Against Adult Cotylophoron cotylophorum (Paramphistomidae) Nahla A. Radwan, Amal I. Khalil, Amera E. Wahdan Department of Zoology, Faculty of Science, University of Tanta, Tanta, Egypt Received: March, 2012 Accepted: May, 2012 ABSTRACT Background: Plant-based anti-helminthics have been reported for their safety and eco-friendly properties. They are used as alternatives for toxic chemical drugs. Allium sativum (garlic) has shown antihelminthic action in vitro and in vivo against many helminthes. Objective: The present study was designed to evaluate the in vitro antihelminthic activity of A. sativum in comparison with two commonly used antihelminthic drugs; albendazole and niclosamide against the cattle amphistome, Cotylophoron cotylophorum. Material and Methods: Live adult C. cotylophorum worms were collected from the rumen and reticulum of slaughtered cattle. Twelve media (natural calf serum, RPMI 1640 in ten formulas and normal saline) were evaluated to choose the most favorable one for incubation of worms during the study. Different concentrations of albendazole, niclosamide and alcoholic extract of A. sativum were tested in vitro against C. cotylophorum. Treated worms were examined after 2, 4, 8, 12 and 24 hours and the mortality rate was calculated in all experiments. The effect of the sub-lethal concentrations of albendazole and A. sativum on the tegument of the worm was evaluated by scanning electron microscopy (SEM). Results: Albendazole was highly effective against adult C. cotylophorum, where it exhibited dose-dependent lethal activity at different concentrations. Niclosamide was less effective, with high mortality rates recorded at relatively higher concentrations than albendazole. SEM revealed remarkable changes in the tegument and muscles of adult C. cotylophorum treated with a sub-lethal concentration of albendazole (1.5 mg/L) for eight hours. The whole tegument was deformed and papillae were hardly seen as swollen bodies. Numerous blebs and crater-like structures covered the whole tegument. A. sativum alcoholic extract gave high mortality rate at a relatively low concentration. SEM of adult worms treated with a sub-lethal concentration of A. sativum alcoholic extract (1.0 mg/L) revealed moderate changes in the tegument and a more severe effect on the muscle integrity. The mouth appeared flaccid and slightly retracted and the tegument surrounding it appeared feebly damaged and corrugated. The papillae lost their uniform structure. The acetabulum appeared retracted and lost its specific shape. Conclusion: The present study revealed that A. sativum alcoholic extract has an antihelminthic effect against adult C. cotylophorum at low concentrations. Garlic-based antihelminthic product may be used against rumen cattle amphistomes as an alternative for the commonly used chemical drugs. Keywords: Cotylophoron cotylophorum, Albendazole, Niclosamide, Allium sativum, In Vitro, Tegument, SEM. Corresponding author: Amal I. Khalil, [email protected] INTRODUCTION genital atrium of cotylephron type surrounded by Cotylophoron cotylophorum is a digenetic trematode that muscularized genital sucker in the first third of the body. parasitizes the rumen and reticulum of livestock. It has The pathogenic effect of the worm is associated with a bean-shaped body that measures about 12±1.68 mm the intestinal phase of infection. Young flukes are plug- length and 4±0.7 mm width(1). The body is characterized feeders causing severe erosions of the duodenal mucosa. by a well developed subterminal acetabulum and Adults destroy part of rumen and reticulum lining and Personal non-commercial use only. PUJ copyright © 2011. All rights reserved PUJ; 2012, 5(2): 135-146 Allium sativum against Adult C. cotylophorum cause inflammation of the intestine. In heavy infections, to albendazole and niclosamide in order to find a safe enteritis, edema, hemorrhage and ulceration may occur. plant-based antihelminthic as an alternative to the toxic Paramphistomiasis is a disease of prime economic chemotherapeutic agents. The antihelminthic activity importance to the animal industry, causing serious loss in was evaluated by scanning electron microscopy (SEM) wool, meat and milk production(2). to detect ultrastructural morphological changes of treated Antihelminthics are commonly used against rumen worms. flukes. Some of these chemotherapeutic agents are effective against immature flukes, others are effective MATERIALS AND METHODS against mature stages and few are lethal to both. The most commonly used in vivo antihelminthics against Collection of worms: Live C. cotylophorum worms paramphistomes are niclosamide, oxyclosanide, were collected from the rumen and reticulum of cattle triclabendazole and albendazole(3-9). Albendazole, immediately after being slaughtered. Live worms were marketed as Albenza, Eskazole, Zentel and Andazol, kept in 0.9% sodium chloride solution (normal saline) for is a member of the benzimidazoles indicated for the further investigations. treatment of a variety of worm infestations. Its efficiency Selection of the appropriate medium for maintenance against rumen amphistomes in general and against C. of worms during the study experiments: The collected cotylophorum infection in cattle was reported(10-12). worms were divided into groups (8 worms each) The high incidence of resistance to antihelminthic drugs and incubated in different media to choose the most of livestock, in addition to the relative toxicity and side appropriate for in vitro maintenance of worms during effects of many of these drugs, urge the necessity of the study experiments. Twelve media (Table 1) were finding alternative safe and eco-friendly agents against tested including normal saline, calf serum, RPMI 1640 helminthes. This applies to plant-based antihelminthics medium, and nine formulas prepared by modifications that have been used to destroy and expel parasitic worms of RPMI 1640 medium (Sigma-Aldrich company, USA). (13,14) from the gastrointestinal tract . Calf serum was separated by centrifugation from blood Allium sativum (garlic) contains components that show samples obtained from calves in slaughter house, and antiparasitic effects(14). A recent review analyzed the kept at 0ºC for further use(17). Ten ml of each medium active components of different herbs, including A. together with 2 ml of sterilization solution (streptomycin sativum that could be used as drug targets in parasitic and penicillin) were applied to each group of worms diseases(15). Alliin found in the intact bulb is easily in sterile Petri-dishes, and incubated at 37º C and pH converted to allicin (diallyl thiosulphinate) which is 7.4 for 24 hours. The worms were observed visually responsible for the characteristic flavor ofA. sativum and for activity and by mechanical stimulation using a (16) its antimicrobial properties . dissecting needle(18). The mortality rate was calculated In the present study, C. cotylophorum, collected in all experiments according to the following equation: from cattle, was chosen as a model to study the Mortality rate = (Number of dead worms/Total number antihelminthic activity of Allium sativum in comparison of cultivated worms)X100(19). Table (1): Concentrations of different media used to select the appropriate one for maintenance of worms during the study experiments. Composition Media PRMI% Normal saline%* Natural Calf serum% 1 Normal saline* 0 100 0 2 Natural calf serum 0 0 100 3 RPMI 1640 Formula 1 100 0 0 4 RPMI 1640 Formula 2 90 10 0 5 RPMI 1640 Formula 3 80 20 0 6 RPMI 1640 Formula 4 70 30 0 7 RPMI 1640 Formula 5 60 40 0 8 RPMI 1640 Formula 6 50 50 0 9 RPMI 1640 Formula 7 40 60 0 10 RPMI 1640 Formula 8 10 90 0 11 RPMI 1640 Formula 9 50 0 50 12 RPMI 1640 Formula 10 70 0 30 * 0.9% Sodium chloride solution 136 Radwan et al., Antihelminthic agents: The in vitro activity of A. sativum Statistical analysis: All values were expressed as mean alcoholic extract on C. cotylophorum was studied in ± standard deviation (SD). comparison to that of albendazole (Methyl 5-propylthio- 2-benzimidazolecarbamate) and niclosamide (5-chloro- RESULTS N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide) (Adwia Company, Egypt). Dried bulbs of A. sativum Incubation of C. cotylophorum in different media showed were pounded and extracted with 70% ethanol (10 that natural calf serum was the most appropriate medium gm/L) for preparation of alcoholic extract (14). Different as observed by the high activity and low mortality rates concentrations of albendazole (0.05, 0.25, 0.5, 1.5 and of the worms during the exposure period (24 hours) 2.5 mg/L), niclosamide (0.25, 0.5, 1.5, 2.5, 3.5, 4.5and when compared with other media (Table 2). Accordingly, 5.5mg/L) and A. sativum alcoholic extract (0.1, 0.2, 0.3, natural calf serum was selected for worm incubation to 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 and 1 mg/L) were prepared study the in vitro effect of antihelminthics against C. in distilled water to be tested against C. cotylophorum cotylophorum. worms maintained in the selected medium. In vitro antihelminthic effect of albendazole and Evaluation of antihelminthic activity of albendazole, niclosamide: The antihelminthic effect of different niclosamide and A. sativum alcoholic extract against concentrations of albendazole and niclosamide against adult C. cotylophorum: Ten ml of each concentration of adult C. cotylophorum for 24 hours exposure is shown the antihelminthic agents were applied to a group of 8 in table (3). A high albendazole concentration of 1.5 worms of the same length (10-12 mm) maintained in 10 mg/L showed high mortality rate (95.5%) after 8 hours ml of the selected medium and 2 ml of the sterilization exposure. On the other hand, lower concentrations solution. Each experiment was performed in triplicate (0.05, 0.25 and 0.5 mg/L) allowed worms to survive at optimal temperature (37ºC) and pH 7.4(18). Non- longer, where the mortality rates reached 87.5, 97.2 and treated control groups were included with different 97.5%, respectively after 24 hours.
Load more

Recommended publications
  • Computational Studies of Drug Repurposing Targeting P-Glycoprotein Mediated Multidrug-Resistance Phenotypes in Agents of Neglect
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.12.147926; this version posted June 12, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Computational studies of drug repurposing targeting P- glycoprotein mediated multidrug-resistance phenotypes in agents of neglected tropical diseases Nivedita Jaishankar 1, Sangeetha Muthamilselvan 2, Ashok Palaniappan 1,2* 1 Department of Biotechnology, Sri Venkateswara College of Engineering, Post Bag No. 1, Pennalur, Sriperumbudur Tk 602117. India 2 Department of Bioinformatics, School of Chemical and BioTechnology, SASTRA Deemed University, Thanjavur 613401. India * Corresponding author: [email protected] ABSTRACT Mammalian ABCB1 P-glycoprotein is an ATP- dependent efflux pump with broad substrate specificity associated with cellular drug resistance. Homologous to this role in mammalian biology, the P-glycoprotein of agents of neglected tropical diseases (NTDs) mediates the emergence of multidrug- resistance phenotypes. The clinical and socioeconomic implications of NTDs are exacerbated by the lack of research interest among Big Pharma for treating such conditions. This work aims to characterise P-gp homologues in certain agents of key NTDs, namely (1) Protozoa: Leishmania major, Trypanosoma cruzi; (2) Helminths: Onchocerca volvulus, Schistosoma mansoni. PSI-BLAST searches against the genome of each of these organisms confirmed the presence of P-gp homologues. Each homologue was aligned against five P- gp sequences of known structure, to identify the most suitable template based on sequence homology, phylogenetic nearest neighbor, and query coverage.
    [Show full text]
  • Comparative Genomics of the Major Parasitic Worms
    Comparative genomics of the major parasitic worms International Helminth Genomes Consortium Supplementary Information Introduction ............................................................................................................................... 4 Contributions from Consortium members ..................................................................................... 5 Methods .................................................................................................................................... 6 1 Sample collection and preparation ................................................................................................................. 6 2.1 Data production, Wellcome Trust Sanger Institute (WTSI) ........................................................................ 12 DNA template preparation and sequencing................................................................................................. 12 Genome assembly ........................................................................................................................................ 13 Assembly QC ................................................................................................................................................. 14 Gene prediction ............................................................................................................................................ 15 Contamination screening ............................................................................................................................
    [Show full text]
  • I Comparative Activity of Anthelmintic
    Retour au menu Comparative activity of anthelmintic drugs, mebendazole, praziquantel and albendazole against Hymenolepis M. Gala1 ’ diminufa in experimentally infected S. R. Chin ’ Irats GALAL (MT), CHIN (S. R.). Comparaison de l’action de différents CAVIER and ROSSIGNOL (3) studied the taenicidal anthelminttuques (mébendazole, praziquantel et albendazole) contre properties of albendazole, mebendazole, niclosamide Hymenoleph diminuta chez des rats expérimentalement Infectés. Rev. Elev. Méd. vét. Pays trop., 1987, 40 (2) : 147-150. and praziquantel in experimentally infected mice and found that praziquantel and niclosamide have similar Des rats expérimentalement infectés avec If. diminufa ont été traités par voie orale avec trois anthelminthiques, administrés soit en dose taenicidal propet-ties. unique, soit en tiers de dose 3 jours consécutifs. Le praziquantel (250 mgkg ou 83 mg/k&j 3 fois) et I’alhendazole (800 mgkg ou Now are reported the comparative efficacy of meben- 167 mgkg/j 3 fois) ont totalement éliminé les vers, alors que le dazole, praziquantel and albendazole against experi- mébendazole (500 rng/kg- - ou 167 mg/kg/i- -. 3 fois) ne les a aue oartielle- mental infection of rats with H. diminuta, using single ment éliminés, avec une efficacité de 76 p. 160. Parmi ces j anthel- and divided oral doses for 3 consecutive days, 30 days mlnthlques, il n’a pas été relevé de différence signiiïcative d’efkacité entre les différents dosages pour chaque traitement. Aucune toxicité after infection. n’est apparue chez les rats traités. Mots CES : Rat - Helminthosc - Hymenolepis diminuta - Anthelminthique - Mébendazole - Prazi- quantel - Albendazole - Infection expérimentale. MATERIALS AND METHODS INTRODUCTION Definitive and intermediate hosts Albino rats (Rattus norvegicus) of both sexes and H.
    [Show full text]
  • Redalyc.Determination of Niclosamide and Its Metabolites in Liver And
    Acta Scientiae Veterinariae ISSN: 1678-0345 [email protected] Universidade Federal do Rio Grande do Sul Brasil Kartalovic, Brankica; Pucarevic, Mira; Markovic, Zoran; Stankovic, Marko; Novakov, Nikolina; Pelic, Milos; Cirkovic, Miroslav Determination of Niclosamide and its Metabolites in Liver and Muscles of Common Carp (Cyprinus carpio) Fingerlings Acta Scientiae Veterinariae, vol. 45, 2017, pp. 1-6 Universidade Federal do Rio Grande do Sul Porto Alegre, Brasil Available in: http://www.redalyc.org/articulo.oa?id=289053641022 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative Acta Scientiae Veterinariae, 2017. 45: 1490. RESEARCH ARTICLE ISSN 1679-9216 Pub. 1490 Determination of Niclosamide and its Metabolites in Liver and Muscles of Common Carp (Cyprinus carpio) Fingerlings Brankica Kartalović1 , Mira Pucarević2, Zoran Marković3, Marko Stanković3, Nikolina Novakov4, Milos Pelić1 & Miroslav Ćirković1 ABSTRACT Background: Niclosamide is a medication used to treat tapeworm infestation in animals and humans. It is also lampricide and molluscicide, and can be used in in agriculture as a pesticide. In the treatment of parasitic diseases in fish, niclosamide can be used as bath or mixed with the feed. Its most important use in common carp (Cyprinus carpio) is for the treatment of Bothriocephalus acheilognathi, which is a very common parasite in this fish species. The aim of this study was to de- termine the concentrations of niclosamide (NIC) and its metabolite 2-chloro 4-nitro aniline (CNA) and 5-chloro salycilic acid (CSA) in the liver and muscles of common carp fingerlings.
    [Show full text]
  • Praziquantel Treatment in Trematode and Cestode Infections: an Update
    Review Article Infection & http://dx.doi.org/10.3947/ic.2013.45.1.32 Infect Chemother 2013;45(1):32-43 Chemotherapy pISSN 2093-2340 · eISSN 2092-6448 Praziquantel Treatment in Trematode and Cestode Infections: An Update Jong-Yil Chai Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul, Korea Status and emerging issues in the use of praziquantel for treatment of human trematode and cestode infections are briefly reviewed. Since praziquantel was first introduced as a broadspectrum anthelmintic in 1975, innumerable articles describ- ing its successful use in the treatment of the majority of human-infecting trematodes and cestodes have been published. The target trematode and cestode diseases include schistosomiasis, clonorchiasis and opisthorchiasis, paragonimiasis, het- erophyidiasis, echinostomiasis, fasciolopsiasis, neodiplostomiasis, gymnophalloidiasis, taeniases, diphyllobothriasis, hyme- nolepiasis, and cysticercosis. However, Fasciola hepatica and Fasciola gigantica infections are refractory to praziquantel, for which triclabendazole, an alternative drug, is necessary. In addition, larval cestode infections, particularly hydatid disease and sparganosis, are not successfully treated by praziquantel. The precise mechanism of action of praziquantel is still poorly understood. There are also emerging problems with praziquantel treatment, which include the appearance of drug resis- tance in the treatment of Schistosoma mansoni and possibly Schistosoma japonicum, along with allergic or hypersensitivity
    [Show full text]
  • Optimisation and Validation of a Sensitive Bioanalytical Method For
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.13.426426; this version posted January 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Optimisation and validation of a sensitive bioanalytical method for niclosamide. Usman Arshad1,3, Henry Pertinez1,3, Helen Box1,3, Lee Tatham1,3, Rajith KR Rajoli1,3, Megan Neary1,3, Joanne Sharp1,3, Anthony Valentijn1,3, James Hobson2,3, Catherine Unsworth2,3, Andrew Dwyer2,3, Alison Savage2,3, Tom O Mcdonald2,3, Steve P Rannard2,3, Paul Curley1,3, Andrew Owen1,3. 1Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, L7 3NY, UK 2Department of Chemistry, University of Liverpool, Liverpool, L69 3BX, UK 3Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool, Liverpool, L7 3NY, UK Author for correspondence: Dr Paul Curley Department of Pharmacology and Therapeutics Centre of Excellence in Long-acting Therapeutics (CELT) University of Liverpool United Kingdom Tel: +44 (0) 151 795 8560 E-mail: [email protected] Key words: COVID-19, niclosamide, LC-MS/MS, plasma, SARS-CoV-2 Conflicts of interest statement AO and SR have received research funding from AstraZeneca and ViiV and consultancies from Gilead; AO has additionally received funding from Merck and Janssen and consultancies from ViiV and Merck not related to the current paper. No other conflicts are declared by the authors. Funding This work was funded by UKRI using funding repositioned from EP/R024804/1 as part of the UK emergency response to COVID-19.
    [Show full text]
  • Overview of Planned Or Ongoing Studies of Drugs for the Treatment of COVID-19
    Version of 16.06.2020 Overview of planned or ongoing studies of drugs for the treatment of COVID-19 Table of contents Antiviral drugs ............................................................................................................................................................. 4 Remdesivir ......................................................................................................................................................... 4 Lopinavir + Ritonavir (Kaletra) ........................................................................................................................... 7 Favipiravir (Avigan) .......................................................................................................................................... 14 Darunavir + cobicistat or ritonavir ................................................................................................................... 18 Umifenovir (Arbidol) ........................................................................................................................................ 19 Other antiviral drugs ........................................................................................................................................ 20 Antineoplastic and immunomodulating agents ....................................................................................................... 24 Convalescent Plasma ...........................................................................................................................................
    [Show full text]
  • Comprehensive Analysis of Drugs to Treat SARS‑Cov‑2 Infection: Mechanistic Insights Into Current COVID‑19 Therapies (Review)
    INTERNATIONAL JOURNAL OF MOleCular meDICine 46: 467-488, 2020 Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review) GEORGE MIHAI NITULESCU1, HORIA PAUNESCU2, STERGHIOS A. MOSCHOS3,4, DIMITRIOS PETRAKIS5, GEORGIANA NITULESCU1, GEORGE NICOLAE DANIEL ION1, DEMETRIOS A. SPANDIDOS6, TAXIARCHIS KONSTANTINOS NIKOLOUZAKIS5, NIKOLAOS DRAKOULIS7 and ARISTIDIS TSATSAKIS5 1Faculty of Pharmacy, 2Faculty of Medicine, ‘Carol Davila’ University of Medicine and Pharmacy, 020956 Bucharest, Romania; 3Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University; 4PulmoBioMed Ltd., Newcastle‑Upon‑Tyne NE1 8ST, UK; 5Department of Forensic Sciences and Toxicology, Faculty of Medicine; 6Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion; 7Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece Received April 20, 2020; Accepted May 18, 2020 DOI: 10.3892/ijmm.2020.4608 Abstract. The major impact produced by the severe acute tions, none have yet demonstrated unequivocal clinical utility respiratory syndrome coronavirus 2 (SARS‑CoV-2) focused against coronavirus disease 2019 (COVID‑19). This work many researchers attention to find treatments that can suppress represents an exhaustive and critical review of all available transmission or ameliorate the disease. Despite the very fast data on potential treatments
    [Show full text]
  • A61k 47/32 (2013.01)
    US0092.594.17B2 (12) United States Patent (10) Patent No.: US 9.259,417 B2 Soll et al. (45) Date of Patent: Feb. 16, 2016 (54) PARASITICIDAL ORAL VETERINARY USPC .......................................................... 514/378 COMPOSITIONS COMPRISING See application file for complete search history. SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF (56) References Cited (71) Applicant: MERIAL INC., Duluth, GA (US) U.S. PATENT DOCUMENTS 3,887.964 A 6, 1975 Richards (72) Inventors: Mark David Soll, Alpharetta, GA (US); 4,284,652 A 8, 1981 Christensen Diane Larsen, Buford, GA (US); Susan 4,327,076 A 4/1982 Puglia et al. Mancini Cady, Yardley, PA (US); Peter 4,393,085 A 7/1983 Spradlin et al. Cheifetz, East Windsor, NJ (US); is: A 2. 3. SE, Izabela Galeska, Newtown, PA (US) 4,997,671- - - A 3/1991 SpanierO C. a. 5,236,730 A 8, 1993 Yamada et al. (73) Assignee: MERLAL, INC., Duluth, GA (US) 5,262,167 A 1 1/1993 Vegesna et al. 5,380,535 A 1/1995 Geyer et al. (*) Notice: Subject to any disclaimer, the term of this 5.439,924 A 8, 1995 Miller patent is extended or adjusted under 35 5,578.336 A 1 1/1996 Monte U.S.C. 154(b) by O. davs. 5,605,889 A 2f1997 Curatolo et al. (b) by yS 5,637,313 A 6, 1997 Chau 5,753,255 A 5/1998 Chaukin et al. (21) Appl. No.: 14/627,499 5,824,336 A 10/1998 Janset al. (22) Filed: Feb. 20, 2015 5,827,5655:3.
    [Show full text]
  • The Selection of Essential Drugs
    This report contains the collective views of an, international group of experts and does not necessarily represent the decisions or the stated policy of the World Health Organization The selection of essential drugs Second report of the WHO Expert Committee World Health Organization Technical Report Series 641 • World Health Organization Geneva 1979 ISBN 92 4 120641 I © World Health Organization 1979 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. For rights of reproduction or translation of WHO publications, in part or in toto, appli­ cation should be made to the Office of Publications, World Health Organization, Geneva, Switzerland. The World Health Organization welcomes such applications. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers- or boundaries. - The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted; the names of proprietar j products are distinguished by initial capital letters. PRINTED IN SWlTZERL-\'-iD 79/4523 - 10000 - La Concorde CONTENfS Page I. Introduction . 7 2. General considerations 8 3. Guidelines for the selection of pharmaceutical forms 8 4. Revised model list of essential drugs .
    [Show full text]
  • Chemotherapeutic Effects of Praziquantel, Niclosamide, Mebendazole And
    [Jpn. J. Parasitol., Vol. 38, No. 4, 236—239, August, 1989] Chemotherapeutic Effects of Praziquantel, Niclosamide, Mebendazole and Bithionol on Larvae and Adults of Hymenolepis nana in Mice JUN MAKI AND TOSHIO YANAGISAWA (Accepted for publication; May 22, 1989) Abstract Praziquantel, niclosamide or mebendazole was orally administered to mice harbouring adult Hymenolepis nana 12 or 12—16 days post-infection. Praziquantel (25 mg/kg) was completely effective at the single administration, similar to the result of Thomas and Gonnert (1977). Worm reduction by niclosamide was about 25—50% at a single dose of 100 or 500 mg/kg and at five successive doses of 100 mg/kg/day. Worm reduction due to mebendazole was about 10—20% at a single dose of 100 or 500 mg/kg while the drug completely eliminated adult worms at five successive doses of 100 mg/kg/day. Praziquantel (25 mg/kg/day), niclosamide (500 mg/kg/day), mebendazole (500 mg/kg/day) or bithionol (500 mg/kg/day) was administered to mice harbouring cysticercoids of H. nana in the intestinal villi for 3 consecutive days (1—3 days post-infection). None of these drugs had larvicidal effect. However, praziquantel (25 mg/kg) was completely effective against larval H. nana in the intestinal lumen when the single dose was given 5 days post- infection or later. Key words: praziquantel, niclosamide, mebendazole, bithionol, Hymenolepis nana Introduction in the villi. To treat H. nana infection completely, cysticercoids as well as adults should be Recently, praziquantel, niclosamide, benzi- eliminated. To the best of the present authors' midazoles, bithionol, paromomycin sulphate and knowledge, however, no data have been pre other drugs have been used to treat human sented so far indicating the possibility of suc cestode infections.
    [Show full text]
  • Niclosamide Is Active in Vitro Against Mycetoma Pathogens
    molecules Article Niclosamide Is Active In Vitro against Mycetoma Pathogens Abdelhalim B. Mahmoud 1,2,3,† , Shereen Abd Algaffar 4,† , Wendy van de Sande 5, Sami Khalid 4 , Marcel Kaiser 1,2 and Pascal Mäser 1,2,* 1 Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; [email protected] (A.B.M.); [email protected] (M.K.) 2 Faculty of Science, University of Basel, 4001 Basel, Switzerland 3 Faculty of Pharmacy, University of Khartoum, Khartoum 11111, Sudan 4 Faculty of Pharmacy, University of Science and Technology, Omdurman 14411, Sudan; [email protected] (S.A.A.); [email protected] (S.K.) 5 Erasmus Medical Center, Department of Medical Microbiology and Infectious Diseases, 3000 Rotterdam, The Netherlands; [email protected] * Correspondence: [email protected]; Tel.: +41-61-284-8338 † These authors contributed equally to this work. Abstract: Redox-active drugs are the mainstay of parasite chemotherapy. To assess their repurposing potential for eumycetoma, we have tested a set of nitroheterocycles and peroxides in vitro against two isolates of Madurella mycetomatis, the main causative agent of eumycetoma in Sudan. All the tested compounds were inactive except for niclosamide, which had minimal inhibitory concentrations of around 1 µg/mL. Further tests with niclosamide and niclosamide ethanolamine demonstrated in vitro activity not only against M. mycetomatis but also against Actinomadura spp., causative agents of actinomycetoma, with minimal inhibitory concentrations below 1 µg/mL. The experimental compound MMV665807, a related salicylanilide without a nitro group, was as active as niclosamide, indicating that the antimycetomal action of niclosamide is independent of its redox chemistry (which Citation: Mahmoud, A.B.; Abd Algaffar, S.; van de Sande, W.; Khalid, is in agreement with the complete lack of activity in all other nitroheterocyclic drugs tested).
    [Show full text]